IVOSIDENIB | N211192 | SERVIER PHARMACEUTICALS LLC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2022-01423 | 10610125 | IPR | Rigel Pharmaceuticals, Inc. | Terminated-Settled | 2022-08-15 | 2023-01-06 |
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9474779 | Aug 19, 2033 | — | Yes | Yes | — | |
| 9850277 | Jan 18, 2033 | — | Yes | Yes | — | |
| 9968595 | Mar 13, 2035 | — | — | Yes | — | |
| 10449184 | Mar 13, 2035 | — | — | Yes | — | — |
| 10610125 | Jun 21, 2030 | — | — | — | — | |
| 10653710 | Oct 18, 2036 | — | — | — | — | |
| 10717764 | Jan 18, 2033 | — | — | — | — | |
| 10799490 | Mar 13, 2035 | — | — | Yes | — | |
| 10980788 | Jun 7, 2039 | — | — | — | — | |
| 11667673 | Jan 18, 2033 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| I-924 | Oct 24, 2026 | < 1 year |
| ODE-242 | May 2, 2026 | Expired |
| ODE-368 | Aug 25, 2028 | Active |
| ODE-447 | Oct 24, 2030 | Active |